Amicus Therapeutics Inc (FOLD)
9.23
-0.25
(-2.64%)
USD |
NASDAQ |
May 10, 16:00
9.235
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Cash from Operations (Quarterly): -29.70M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -29.70M |
| December 31, 2023 | 3.458M |
| September 30, 2023 | -38.35M |
| June 30, 2023 | -16.13M |
| March 31, 2023 | -18.07M |
| December 31, 2022 | -80.77M |
| September 30, 2022 | -11.63M |
| June 30, 2022 | -15.86M |
| March 31, 2022 | -58.32M |
| December 31, 2021 | -70.51M |
| September 30, 2021 | -23.70M |
| June 30, 2021 | -35.92M |
| March 31, 2021 | -72.35M |
| December 31, 2020 | -49.82M |
| September 30, 2020 | -42.01M |
| June 30, 2020 | -33.52M |
| March 31, 2020 | -107.94M |
| December 31, 2019 | -57.83M |
| September 30, 2019 | -55.55M |
| June 30, 2019 | -58.48M |
| March 31, 2019 | -78.55M |
| December 31, 2018 | -60.68M |
| September 30, 2018 | -132.76M |
| June 30, 2018 | -57.00M |
| March 31, 2018 | -49.52M |
| Date | Value |
|---|---|
| December 31, 2017 | -73.03M |
| September 30, 2017 | -48.90M |
| June 30, 2017 | -41.91M |
| March 31, 2017 | -49.84M |
| December 31, 2016 | -31.60M |
| September 30, 2016 | -40.88M |
| June 30, 2016 | -32.74M |
| March 31, 2016 | -44.94M |
| December 31, 2015 | -35.51M |
| September 30, 2015 | -21.02M |
| June 30, 2015 | -22.64M |
| March 31, 2015 | -20.98M |
| December 31, 2014 | -14.51M |
| September 30, 2014 | -15.12M |
| June 30, 2014 | -11.82M |
| March 31, 2014 | -10.22M |
| December 31, 2013 | -8.12M |
| September 30, 2013 | -13.51M |
| June 30, 2013 | -10.26M |
| March 31, 2013 | -13.90M |
| December 31, 2012 | -7.374M |
| September 30, 2012 | -7.20M |
| June 30, 2012 | -11.13M |
| March 31, 2012 | -8.039M |
| December 31, 2011 | -12.52M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-107.94M
Minimum
Mar 2020
3.458M
Maximum
Dec 2023
-43.65M
Average
-40.18M
Median
Cash from Operations (Quarterly) Benchmarks
| TG Therapeutics Inc | -8.207M |
| Mersana Therapeutics Inc | -31.96M |
| Geron Corp | -62.25M |
| Insmed Inc | -184.04M |
| InfuSystems Holdings Inc | 4.658M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 7.537M |
| Cash from Financing (Quarterly) | -13.31M |
| Free Cash Flow | -88.03M |
| Free Cash Flow Per Share (Quarterly) | -0.104 |
| Free Cash Flow to Equity (Quarterly) | -32.04M |
| Free Cash Flow to Firm (Quarterly) | -19.40M |
| Free Cash Flow Yield | -3.20% |